WPRIM Management System> DCMS> Journal of Breast Cancer> 2019> 22

Volume: 22

1. Erratum: Basic Findings Regarding Breast Cancer in Korea in 2015: Data from a Breast Cancer Registry Page:153—153
2. Neoadjuvant Therapy Should Be the Standard of Care for Every Node Positive Breast Cancer Patient Page:149—152
3. Durable Response of Androgen Receptor-Positive Male Breast Cancer to Goserelin Page:141—148
4. Whole Exome Sequencing in the Accurate Diagnosis of Bilateral Breast Cancer: a Case Study Page:131—140
5. Central Nervous System Failure in Korean Breast Cancer Patients with HER2-Enriched Subtype: Korean Radiation Oncology Group 16-15 Multicenter Retrospective Study Page:120—130
6. Immediate Breast Reconstruction Does Not Have a Clinically Significant Impact on Adjuvant Treatment Delay and Subsequent Survival Outcomes Page:109—119
7. Young Patients with Hormone Receptor-Positive Breast Cancer Have a Higher Long-Term Risk of Breast Cancer Specific Death Page:96—108
8. Prescription Refill Gap of Endocrine Treatment from Electronic Medical Records as a Prognostic Factor in Breast Cancer Patients Page:86—95
9. CD9 Expression in Tumor Cells Is Associated with Poor Prognosis in Patients with Invasive Lobular Carcinoma Page:77—85
10. Determining Whether High Nodal Burden in Early Breast Cancer Patients Can Be Predicted Preoperatively to Avoid Sentinel Lymph Node Biopsy Page:67—76
11. Human Epidermal Growth Factor Receptor 2-positive Mucinous Carcinoma with Signet Ring Cell Differentiation, Which Showed Complete Response after Neoadjuvant Chemotherapy Page:336—340
12. Solitary Fibrous Tumor of Breast with Anaplastic Areas (Malignant Solitary Fibrous Tumor): A Case Report with Review of Literature Page:326—335
13. Comparison of Digital and Screen-Film Mammography for Breast-Cancer Screening: A Systematic Review and Meta-Analysis Page:311—325
14. Comparative Analysis of Outcomes and Clinicopathological Characteristics of Synchronous and Metachronous Contralateral Breast Cancer: A Study of the SEER Database Page:297—310
15. The Benefit of Post-Mastectomy Radiotherapy in ypN0 Patients after Neoadjuvant Chemotherapy According to Molecular Subtypes Page:285—296
16. Murine Model Study of a New Receptor-Targeted Tracer for Sentinel Lymph Node in Breast Cancer Page:274—284
17. Validation of a Risk Score Incorporating Tumor Characteristics into the American Joint Committee on Cancer Anatomic Stage for Breast Cancer Page:260—273
18. High Survivin and Low Zinc Finger of the Cerebellum 1 Expression Indicates Poor Prognosis in Triple-negative Breast Carcinoma Page:248—259
19. Cell Division Cycle Associated 8 Is a Key Regulator of Tamoxifen Resistance in Breast Cancer Page:237—247
20. miR-148b-3p, miR-190b, and miR-429 Regulate Cell Progression and Act as Potential Biomarkers for Breast Cancer Page:219—236
21. The Correlation between IL-1β-C31T Gene Polymorphism and Susceptibility to Breast Cancer Page:210—218
22. Inhibition of Indoleamine 2,3-Dioxygenase Enhances the Therapeutic Efficacy of Immunogenic Chemotherapeutics in Breast Cancer Page:196—209
23. Doxorubicin Promotes Migration and Invasion of Breast Cancer Cells through the Upregulation of the RhoA/MLC Pathway Page:185—195
24. Overexpression of Tumor Protein p53-regulated Apoptosis-inducing Protein 1 Regulates Proliferation and Apoptosis of Breast Cancer Cells through the PI3K/Akt Pathway Page:172—184
25. Insights into Hypoxia: Non-invasive Assessment through Imaging Modalities and Its Application in Breast Cancer Page:155—171
26. Primary Histiocytic Sarcoma Presenting as a Breast Mass: A Case Report Page:491—496
27. Human Epidermal Growth Factor Receptor 2-Subtype Invasive Ductal Carcinoma Recurring as Basal-Human Epidermal Growth Factor Receptor 2-Subtype Squamous Cell Carcinoma Page:484—490
28. Early Rehabilitation after Total Mastectomy and Immediate Reconstruction with Tissue Expander Insertion in Breast Cancer Patients: A Retrospective Case-control Study Page:472—483
29. Gastric Complications after Adjuvant Radiotherapy for Breast Cancer Page:464—471
30. Measuring Tumor Extent Based on Subtypes Using Magnetic Resonance Imaging: Radiologic-Pathologic Discordance and High Positive Margin Rates in Breast Cancer Page:453—463
31. Changes in Biomarker Status in Metastatic Breast Cancer and Their Prognostic Value Page:439—452
32. The Role of Neutrophil-lymphocyte Ratio and Platelet-lymphocyte Ratio in Predicting Neoadjuvant Chemotherapy Response in Breast Cancer Page:425—438
33. Potential Benefits of Neoadjuvant Chemotherapy in Clinically Node-Positive Luminal Subtype⁻ Breast Cancer Page:412—424
34. Weight Gain during Neoadjuvant Chemotherapy is Associated with Worse Outcome among the Patients with Operable Breast Cancer Page:399—411
35. Prediction of Late Breast Cancer-Specific Mortality in Recurrence-Free Breast Cancer Survivors Treated for Five Years with Tamoxifen Page:387—398
36. In Vitro and In Vivo Study on the Effect of Lysosome-associated Protein Transmembrane 4 Beta on the Progression of Breast Cancer Page:375—386
37. Anticancer Activity of Tubulosine through Suppression of Interleukin-6-Induced Janus Kinase 2/Signal Transducer and Activation of Transcription 3 Signaling Page:362—374
38. Druggable Molecular Targets for the Treatment of Triple Negative Breast Cancer Page:341—361
39. Ribociclib-Related Stevens–Johnson Syndrome: Oncologic Awareness, Case Report, and Literature Review Page:661—666
40. Salivary Duct Cancer Metastasis Mimicking Primary Breast Cancer: A Case Report and Review Page:653—660
41. Clinical Effects of Hypomethylating Agents in Patients with Newly Diagnosed Myelodysplastic Syndrome Who Received DNA-Damaging Chemotherapy for Metastatic Breast Cancer Page:647—652
42. Skin-sparing Mastectomy and Immediate Nipple Graft for Large, Ptotic Breast Page:641—646
43. Intraoperative Specimen Mammography for Margin Assessment in Breast-Conserving Surgery Page:635—640
44. Amenorrhea and Menopause in Patients with Breast Cancer after Chemotherapy Page:624—634
45. Oncologic Outcomes of Nipple-Sparing Mastectomy with Immediate Breast Reconstruction in Patients with Tumor–Nipple Distance Less than 2.0 cm Page:613—623
46. Omission of Chemotherapy for the Treatment of Mucinous Breast Cancer: A Nationwide Study from the Korean Breast Cancer Society Page:599—612
47. Contralateral Breast Cancer and Ipsilateral Breast Tumor Recurrence in BRCA1/2 Carriers and Non-Carriers at High-Risk of Hereditary Breast Cancer Page:587—598
48. A Validation Study of a Multiple Reaction Monitoring-Based Proteomic Assay to Diagnose Breast Cancer Page:579—586
49. Notch1 in Tumor Microvascular Endothelial Cells and Tumoral miR-34a as Prognostic Markers in Locally Advanced Triple-Negative Breast Cancer Page:562—578
50. Prognostic Role of KRAS mRNA Expression in Breast Cancer Page:548—561
51. c-Myc-Induced Long Non-Coding RNA Small Nucleolar RNA Host Gene 7 Regulates Glycolysis in Breast Cancer Page:533—547
52. Kinesin Family Member 11 Enhances the Self-Renewal Ability of Breast Cancer Cells by Participating in the Wnt/β-Catenin Pathway Page:522—532
53. Predictive and Prognostic Roles of Pathological Indicators for Patients with Breast Cancer on Neoadjuvant Chemotherapy Page:497—521